お知らせ • Dec 28
Flora Growth Corp. Announces Executive Changes
On December 23, 2022, Flora Growth Corp. completed its previously reported acquisition of all the issued and outstanding common shares of Franchise Global Health Inc. Effective December 23, 2022 and in connection with the Arrangement, the Company expanded the size of its board of directors from seven to nine directors. Effective December 23, 2022 and in connection with the Arrangement, the Board appointed Clifford Starke and Edward Woo as directors of the Company to fill the two vacancies created by the increase in size of the Board. The Board determined that Mr. Woo meets the definition of “independent director” under applicable Nasdaq Stock Market rules. In addition, on December 23, 2022, the Company entered into a consulting agreement with Clifford Starke to serve as President of the Company and an employment agreement with Dany Vaiman to serve as Senior VP Finance of the Company. Clifford Starke, age 39, will serve as the Company’s President. From February 2022 through the closing of the Arrangement, he served as the Executive Chairman and Chief Executive Officer of Franchise. Since May 2018, Mr. Starke has served as the Chairman of Hampstead Private Capital Ltd., a Bermuda based merchant bank investing in small to mid-cap, high growth companies in various sectors and primarily focused in the medical cannabis industry. Mr. Starke has over 15 years of investing and public markets experience and, over the last seven years, has acted as a financier, investor and operator of cannabis companies. Mr. Starke holds a Bachelor of Arts degree in History from Queen's University. Edward Woo, age 44, will serve as a member of the Company’s Board of Directors. From August 2021 through the closing of the Arrangement, he served as the President and Chief Operating Officer of Franchise. Mr. Woo is a seasoned business executive with extensive experience in the consumer-packaged goods industry. Over the past 20 years, Mr. Woo focused his efforts on the tobacco industry in the areas of sales, trade marketing, business strategy, political mobilization and government affairs. As a former executive at Rothmans Benson & Hedges Inc. and Philip Morris International, Mr. Woo held several leadership roles which included serving as Head of Regulatory & External Affairs at the Global Headquarters in Lausanne, Switzerland (2016 through 2021) and as Regional Communications Director Latin America and Canada (from 2013 through 2016). Mr. Woo has extensive global experience and strong ties to the European markets and worked closely with over 30 markets in Europe, Middle East, Asia and Latin America on the rollout of Philip Morris’ revolutionary IQOS product, with a particular focus on execution, supply chain, regulation and stakeholder engagement. Mr. Woo holds a BA in Economics from the University of Western Ontario. Dany Vaiman, age 39, will serve as the Company’s Senior VP of Finance. From February 2022 through the closing of the Arrangement, he served as the Chief Financial Officer of Franchise. Prior to that, Mr. Vaiman served as Corporate Controller (from July 2018 to July 2021) and as Assistant Controller (from June 2016 to June 2018) of Torex Gold Resources Inc.- a leading intermediate gold producer listed on the TSX. For seven years, Mr. Vaiman was with Ernst & Young’s Toronto Audit Group, specializing in publicly listed TSX and SEC clients. Mr. Vaiman is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA) in Ontario, a Certified Public Accountant (CPA) in Illinois, and holds a Bachelor of Business Administration (Honours) from the Schulich School of Business. Effective December 16, 2022, James Choe, the Company’s Chief Strategy Officer, resigned from his position with the Company. Mr. Choe’s resignation was not as a result of any disagreements with the Company, the Board or the Company’s operations, policies, or practices.